123 related articles for article (PubMed ID: 36727673)
1. Molecular epidemiology of human papillomavirus in pregnant women in Burkina Faso.
Kabre KM; Ouermi D; Zohoncon TM; Traore FPW; Gnoumou OPP; Ouedraogo RA; Yonli AT; Bado P; Ouedraogo P; Ouedraogo TC; Yelemkoure TE; Kuassi-Kpede PA; Obiri-Yeboah D; Ouedraogo CMR; Simpore J
Biomol Concepts; 2022 Jan; 13(1):334-340. PubMed ID: 36727673
[TBL] [Abstract][Full Text] [Related]
2. Genotypic distribution of human oncogenic papillomaviruses in sexually active women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins regions.
Ouedraogo RA; Zohoncon TM; Traore IMA; Ouattara AK; Guigma SP; Djigma FW; Obiri-Yeboah D; Ouedraogo C; Simpore J
Biomol Concepts; 2020 May; 11(1):125-136. PubMed ID: 32417758
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso.
Traore IMA; Zohoncon TM; Ndo O; Djigma FW; Obiri-Yeboah D; Compaore TR; Guigma SP; Yonli AT; Traore G; Ouedraogo P; Ouedraogo CMR; Traore Y; Simpore J
Pak J Biol Sci; 2016; 19(7):306-311. PubMed ID: 29023032
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa.
Ouedraogo RA; Zohoncon TM; Guigma SP; Angèle Traore IM; Ouattara AK; Ouedraogo M; Djigma FW; Obiri-Yeboah D; Ouedraogo C; Simpore J
Papillomavirus Res; 2018 Dec; 6():22-26. PubMed ID: 30244072
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of high-risk human papillomavirus (HPV) infection among sexually active women in Ouagadougou.
Salambanga C; Zohoncon TM; Traoré IMA; Ouedraogo RA; Djigma WF; Ouédraog C; Simpore J
Med Sante Trop; 2019 Aug; 29(3):302-305. PubMed ID: 31573526
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Transmission and Persistence in Pregnant Women and Neonates.
Khayargoli P; Niyibizi J; Mayrand MH; Audibert F; Monnier P; Brassard P; Laporte L; Lacaille J; Zahreddine M; Bédard MJ; Girard I; Francoeur D; Carceller AM; Lacroix J; Fraser W; Coutlée F; Trottier H;
JAMA Pediatr; 2023 Jul; 177(7):684-692. PubMed ID: 37213128
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology and characterization of high-risk genotypes of human Papillomavirus in a population of sexually active adolescents in Ouagadougou].
Ouédraogo CM; Rahimy RM; Zohoncon TM; Djigma FW; Yonli AT; Ouermi D; Sanni A; Lankoande J; Simpore J
J Gynecol Obstet Biol Reprod (Paris); 2015 Oct; 44(8):715-22. PubMed ID: 25636785
[TBL] [Abstract][Full Text] [Related]
8. Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso.
Traore IM; Zohoncon TM; Dembele A; Djigma FW; Obiri-Yeboah D; Traore G; Bambara M; Ouedraogo C; Traore Y; Simpore J
Biomed Res Int; 2016; 2016():7092583. PubMed ID: 27525275
[TBL] [Abstract][Full Text] [Related]
9. Characterization of High-risk Oncogenic Human Papillomavirus Genotypes in Histologically Confirmed Ear, Nose and Throat (Ent) Cancers in Burkina Faso.
Ilboudo M; Zohoncon TM; Traore EMA; Traore IMA; Kande A; Djigma FW; Obiri-Yeboah D; Gyebre YMC; Simpore J
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3429-3435. PubMed ID: 31759369
[TBL] [Abstract][Full Text] [Related]
10. Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso.
Maria H; Dana H; Françoise M; Michael P; Jürgen W
Arch Gynecol Obstet; 2018 Oct; 298(4):789-796. PubMed ID: 30120545
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology, characterization of genotypes of human papillomavirus in a population of women in Ouagadougou].
Ouedraogo CM; Djigma FW; Bisseye C; Sagna T; Zeba M; Ouermi D; Karou SD; Pietra V; Buelli F; Ghilat-Avoid-Belem NW; Sanogo K; Sempore J; Moret R; Pignatelli S; Nikiema JB; Simpore J
J Gynecol Obstet Biol Reprod (Paris); 2011 Nov; 40(7):633-8. PubMed ID: 21737213
[TBL] [Abstract][Full Text] [Related]
12. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
Kelly HA; Ngou J; Chikandiwa A; Sawadogo B; Gilham C; Omar T; Lompo O; Doutre S; Meda N; Weiss HA; Delany-Moretlwe S; Segondy M; Mayaud P;
PLoS One; 2017; 12(3):e0174117. PubMed ID: 28333966
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso.
Djigma FW; Ouédraogo C; Karou DS; Sagna T; Bisseye C; Zeba M; Ouermi D; Gnoula C; Pietra V; Ghilat-Avoid-Belem NW; Sanogo K; Sempore J; Pignatelli S; Ferri AM; Nikiema JB; Simpore J
Acta Trop; 2011 Mar; 117(3):202-6. PubMed ID: 21167118
[TBL] [Abstract][Full Text] [Related]
14. Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso.
Low A; Didelot-Rousseau MN; Nagot N; Ouedraougo A; Clayton T; Konate I; Van de Perre P; Segondy M; Mayaud P
Sex Transm Infect; 2010 Oct; 86(5):342-4. PubMed ID: 20410079
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of high-risk humanpapillomavirus genotypes in women with or without cervical lesions at VIA/VILI in Kara, Togo.
Dolou E; Kuassi-Kpede A; Zohoncon TM; Traore IM; Katawa G; Ouedraogo AR; Traore EM; Bado P; Ouedraogo CT; Djigma F; Aboubakari AS; Karou SD; Simpore J
Afr Health Sci; 2021 Dec; 21(4):1715-1721. PubMed ID: 35283946
[TBL] [Abstract][Full Text] [Related]
16. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso.
Didelot-Rousseau MN; Nagot N; Costes-Martineau V; Vallès X; Ouedraogo A; Konate I; Weiss HA; Van de Perre P; Mayaud P; Segondy M;
Br J Cancer; 2006 Aug; 95(3):355-62. PubMed ID: 16832413
[TBL] [Abstract][Full Text] [Related]
18. Human papillomaviruses prevalence and genital co-infections in HIV-seropositive women in Ouagadougou (Burkina Faso).
Sagna T; Djigma F; Zeba M; Bisseye C; Karou SD; Ouermi D; Pietra V; Gnoula C; Sanogo K; Nikiema JB; Simpore J
Pak J Biol Sci; 2010 Oct; 13(19):951-5. PubMed ID: 21313918
[TBL] [Abstract][Full Text] [Related]
19. Association of TNF-α-308G/A and IL-18 Polymorphisms with risk of HPV infection among sexually active women in Burkina Faso.
Traore IMA; Zohoncon TM; Djigma FW; Compaore TR; Traore Y; Simpore J
Biomol Concepts; 2020 Apr; 11(1):97-101. PubMed ID: 32304293
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urine and self-collected vaginal samples for detecting human papillomavirus DNA in pregnant women.
Franciscatto LG; Silva CM; Barcellos RB; Angeli S; Silva MS; Almeida SE; Rossetti ML
Int J Gynaecol Obstet; 2014 Apr; 125(1):69-72. PubMed ID: 24447413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
